The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor α-mediated apoptosis by activation of phosphoinositol 3-kinase and β-catenin

Journal of General Virology

Volumn 88, Issue 12, 2007, Pages 3275-3285

  Pan, Jingbo ^a   Lian, Zhaorui ^a   Wallet, Sarah ^a   Feitelson, Mark A ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA CATENIN; CASPASE 3; CASPASE 8; CHLORAMPHENICOL ACETYLTRANSFERASE; FAS LIGAND; HEPATITIS B VIRUS X PROTEIN; PROTEIN KINASE B; PROTEIN URG7; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UPREGULATED GENE CLONE 7 PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHRONIC HEPATITIS; CONTROLLED STUDY; GENE OVEREXPRESSION; HEPATITIS B; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

APOPTOSIS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL LINE, TUMOR; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; PHOSPHOTRANSFERASES; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

BACTERIA (MICROORGANISMS); HEPATITIS B VIRUS;

EID: 36749058869     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83214-0     Document Type: Article

References (53)

1. Aden, D. P., Fogel, A., Plotkin, S., Damjanov, I. & Knowles, B. B. (1979). Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282, 615-616.
2. Amid, K. I. & Richmond, A. (2005). Role of nuclear factor-κ B in melanoma. Cancer Metastasis Rev 24, 301-313.
3. Beasley, R. P. & Hwang, L. Y. (1984). Epidemiology of hepatocellular carcinoma. In Viral Hepatitis and Liver Disease (Proceedings of the 1984 International Symposium on Viral Hepatitis), pp. 209-224. Edited by G. N. Vyas, J. L. Dienstag & J. H. Hoofnagle. Orlando: Grune and Stratton.
4. Berra, E., Diaz-Meco, M. T. & Moscat, J. (1998). The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 273, 10792-10797.
5. Carruba, G., Cervello, M., Miceli, M. D., Farruggio, R., Notarbartolo, M., Virruso, L., Giannitrapani, L., Gambino, R., Montalto, G. & Castagnetta, L. (1999). Truncated form of β-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells. Ann N Y Acad Sci 886, 212-216.
6. Catz, S. D. & Johnson, J. L. (2003). BCL-2 in prostate cancer: a minireview. Apoptosis 8, 29-37.
7. Chen, H. S., Kaneko, S., Girones, R., Anderson, R. W., Hornbuckle, W. E., Tennant, B. C., Cote, P. J., Gerin, J. L., Purcell, R. H. & Miller, R. H. (1993). The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67, 1218-1226.
8. Chen, R. H., Su, Y. H., Chuang, R. L. & Chang, T. Y. (1998). Suppression of transforming growth factor-β-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Oncogene 17, 1959-1968.
9. Chen, G. G., Lai, P. B. S., Chak, E. C. W., Xu, H., Lee, K. M. & Lau, W. Y. (2001a). Immunohistochemical analysis of proapoptotic Bid levels in chronic hepatitis, hepatocellular carcinoma and liver metastases. Cancer Lett 172, 75-82.
10. Chen, G. G., Lai, P. B. S., Chan, P. K. S., Chak, E. C. W., Yip, J. H. Y., Ho, R. L. K., Leung, B. C. S. & Lau, W. Y. (2001b). Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein. Eur J Cancer 37, 1695-1702.
11. Chisari, F. V. & Ferrari, C. (1995). Hepatitis B virus immunopathology. Springer Semin Immunopathol 17, 261-281.
12. Diao, J., Khine, A. A., Sarangi, F., Hsu, E., Lorio, C., Tibbles, L. A., Woodgett, J. R., Penninger, J. & Richardson, C. D. (2001). X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J. Biol Chem 276, 8328-8340.
13. Fang, J. W., Shen, W. W., Meager, A. & Lau, J. Y. (1996). Activation of the tumor necrosis factor-α system in the liver in chronic hepatitis B virus infection. Am J Gastroenterol 91, 748-753.
14. Feitelson, M. A. & Duan, L. X. (1997). Hepatitis B virus x antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 150, 1141-1157.
15. Feitelson, M. A, Lega, L., Duan, L. X. & Clayton, M. (1993). Characteristics of woodchuck hepatitis X antigen in the livers and sera from chronically infected animals. J Hepatol 17 (Suppl. 3), S24-S34.
16. Gibbs, B. F. & Grabbe, J. (1999). Inhibitors of PI 3-kinase and MEK kinase differentially affect mediator secretion from immunologically activated human basophils. J Leukoc Biol 65, 883-889.
17. Gonzalez-Amaro, R., Garcia-Monzon, C., Garcia-Buey, L., Moreno-Otero, R., Alonso, J. L., Yague, E., Pivel, J. P., Lopez-Cabrera, M., Fernandez-Ruiz, E. & Sanchez-Madrid, F. (1994). Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J Exp Med 179, 841-848.
18. Gottlob, K., Fulco, M., Levrero, M. & Greessmann, A. (1998). The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem 273, 33347-33353.
19. Hussain, M. J., Lau, J. Y., Williams, R. & Vergani, D. (1994). Hepatic expression of tumour necrosis factor-α in chronic hepatitis B virus infection. J Clin Pathol 47, 1112-1115.
20. Jin, Y. M., Yun, C., Park, C., Wang, H. J. & Cho, H. (2001). Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases. J Viral Hepat 8, 322-330.
21. Kekule, A. S., Lauer, U., Weiss, L., Luber, B. & Hofschneider, P. H. (1993). HBV transactivator HBx uses a tumour promoter signalling pathway. Nature 361, 742-745.
22. Lara-Pezzi, E., Majano, P. L., Gomez-Gonzalo, M., Garcia-Monzon, C., Moreno-Otero, R., Levrero, M. & Lopez-Cabrera, M. (1998). The hepatitis B virus X protein up-regulates tumor necrosis factor α gene expression in hepatocytes. Hepatology 28, 1013-1021.
23. Lau, J. Y. N., Sheron, N., Nouri-Aria, K. T., Alexander, G. J. M. & Williams, R. (1991). Increased tumor necrosis factor-α receptor number in chronic hepatitis B virus infection. Hepatology 14, 44-50.
24. Lee, Y. I., Kang-Park, S., Do, S. I. & Lee, Y. I. (2001). The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 276, 16969-16977.
25. Li, H., Zhu, H., Xu, C. J. & Yuan, J. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501.
26. Li, O., Dashwood, W.-M., Zhong, X., Al-Fageeh, M. & Dashwood, R. H. (2004). Cloning of the rat β-catenin gene (Ctnnb1) promoter and its functional analysis compared with the Catnb and CTNNB1 promoters. Genomics 83, 231-242.
27. Lian, Z., Pan, J., Liu, J., Zhu, M., Arbuthnot, P., Kew, M. C. & Feitelson, M. A. (1999). The translation initiation factor, SUI1, maybe a target of HBxAg in hepatocarcinogenesis. Oncogene 18, 1677-1687.
28. Lian, Z., Liu, J., Pan, J., Tufan, N. L. S., Zhu, M., Arbuthnot, P., Kew, M., Clayton, M. M. & Feitelson, M. A. (2001). A cellular gene up-regulated by hepatitis B virus encoded X antigen promotes hepatocellular growth and survival. Hepatology 34, 146-157.
29. Lian, Z., Liu, J., Li, L., Li, X, Tufan, N. L., Clayton, M., Wu, M. C., Wang, H. Y., Arbuthnot, P. & other authors (2003). Up-regulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis. Neoplasia 5, 229-244.
30. Lian, Z., Liu, J., Li, L., Li, X., Clayton, M., Wu, M. C., Wang, H. Y., Arbuthnot P., Kew, M. & other authors (2006). Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with up-regulation of β-catenin. Hepatology 43, 415-424.
31. Luo, K. X, He, H. T., Zhu, Y. F. & Zhang, L. (1997). Hepatocyte Fas expression and DNA damage in chronic hepatitis B. Chin J Intern Med 35, 750-752.
32. Marinos, G., Naoumov, N. V., Rossol, S., Torre, F., Wong, P. Y. N., Gallati, H., Portmann, B. & Williams, R. (1995). Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology 108, 1453-1463.
33. Mikami, I., You, L., He, B., Xu, Z., Batra, S., Lee, A. Y., Mazieres, J., Reguart, N., Uematsu, K & other authors (2005). Efficacy of Wnt-1 monoclonal antibody in sarcoma cells. BMC Cancer 5, 53.
34. Mochizuki, K., Hayashi, N., Hiramatsu, N., Katayama, K., Kawanishi, Y., Kasahara, A., Fusamoto, H. & Kamada, T. (1996). Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 24, 1-7.
35. Morin, P. J. (1999). β-catenin signaling and cancer. Bioessays 21, 1021-1030.
36. Nakabayeshi, H., Taketa, K., Miyano, K., Yamane, T. & Sato, J. (1982). Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 42, 3858-3863.
37. Natoli, G., Avantaggiati, M. L., Chirillo, P., Puri, P. L, Ianni, A., Balsano, C. & Levrero, M. (1994). Ras- and raf-dependent activation of c-Jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 9, 2837-2843.
38. Nollet, F., Berx, G., Molemans, F. & van Roy, F. (1996). Genomic organization of the human β-catenin gene (CTNNB1). Genomics 32, 413-424.
39. Ormestad, M., Astorga, J., Landgren, H., Wang, T., Johansson, B. R., Miura, N. & Carlsson, P. (2006). Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 133, 833-843.
40. Pan, J., Duan, L. X., Sun, B. S. & Feitelson, M. A. (2001). HBV X protein decreases the anti-Fas induced apoptosis in human liver cells by inducing NF-ΚB. J Gen Virol 82, 171-182.
41. Popper, H., Roth, L., Purcell, R. H., Tennant, B. C. & Gerin, J. L. (1987). Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci U S A 84, 866-870.
42. Roskams, T., Libbrecht L., van Dame, B. & Desmet, V. (2000). Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoral cells? J Pathol 191, 150-153.
43. Roy, S. & Nicholson, D. W. (2000). Cross-talk in cell death signaling. J Exp Med 192, F21-F25.
44. Sheron, N., Lau, J., Daniels, H., Goka, J., Eddleston, A., Alexander, G. J. & Williams, R. (1991). increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 12, 241-245.
45. Shin, E. C., Shin, J. S., Park, J. H. & Kim, S. J. (1999). Expression of Fas ligand in human hepatoma cell lines: role of hepatitis B virus X (HBX) in induction of Fas ligand. Int J Cancer 82, 587-591.
46. Sliva, D. (2004). Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr Cancer Drug Targets 4, 327-336.
47. Soriano, P., Montgomery, C., Geske, R. & Bradley, A. (1991). Targeted disruption of the c-src proto-oncogene leads to osteoperosis in mice. Cell 64, 693-702.
48. Suzuki, A., Hayashida, M., Kawano, H., Sugimoto, K., Nakano, T. & Shiraki, K. (2000). Hepatocyte growth factor promotes cell survival from Fas-mediated cell death in hepatocellular carcinoma celJs via Akt activation and Fas-death-inducing signaling complex suppression. Hepatology 32, 796-802.
49. Tiollais, P., Pourcel, C. & Dejean, A. (1985). The hepatitis B virus. Nature 317, 489-495.
50. Wang, W. L., London, W. T., Lega, L. & Feitelson, M. A. (1991a). HBxAg in liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 14, 29-37.
51. Wang, W. L., London, W. T. & Feitelson, M. A. (1991b). HBxAg in HBV carrier patients with liver cancer. Cancer Res 51, 4971-4977.
52. Yang, F., Zeng, Q., Yu, G., Li, S. & Wang, C.-Yu. (2006). Wnt/ β-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 18, 679-687.
53. Zoulim, F., Saputelli, J. & Seeger, C. (1994). Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68, 2026-2030.